Journal Name | Molecular Cancer |
Abbreviation | Mol Cancer |
Journal Start Year | 2002 |
Online ISSN | 1476-4598 |
Subject | Medical |
Sub Subject | Oncology |
Country | United Kingdom (GB) |
Publisher | BioMed Central |
Rss Feed | |
Subscribe | Subscribe Journals |
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.
Molecular Cancer provides an important forum for exciting findings in cancer-related research, presenting an unparalleled opportunity to communicate information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.
Indexing services
All articles published in Molecular Cancer are included in:
An abbreviation is a shortened form of a word or phrase, by any method. It may consist of a group of letters or words taken from the full version of the word or phrase.
The ISO4 Abbreviation of Molecular Cancer is Mol Cancer.
BioMed Central is the publisher of the Molecular Cancer. Visit for all BioMed Central journals, click here : BioMed Central List of Journals.
An International Standard Serial Number is an eight-digit serial number used to uniquely identify a serial publication, such as a magazine. The ISSN is especially helpful in distinguishing between serials with the same title
"Molecular Cancer" Journal , and Online ISSN (eISSN) : 1476-4598
Molecular Cancer eISSN : | 1476-4598 |
The University Grants Commission of India (UGC India) is the primary regulatory body created by the Indian Government in accordance with the UGC Act of 1956 under the Ministry of Human Resource Development.
It has been made responsible for the coordination of Indian Universities, determination of the standards for Indian universities and maintenance of standards of higher education in India.
Yes Molecular Cancer is Indexed By UGC Care. UGC Approved Journals.
PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine at the National Institutes of Health maintain the database as part of the Entrez system of information retrieval.
Yes the Molecular Cancer is PUBMED Indexed Journal.
Molecular Cancer PUBMED Indexed Journal : |
Peer review means that a board of scholarly reviewers in the domain of the journal, review materials they publish for quality of research and adherence to editorial standards of the journal, before articles are accepted for publication.
It’s the ultimate litmus test for scientists and researchers to verify their findings.
When an article on an experiment and its hypothesis is submitted to a scholarly journal for publishing then it is meticulously tested.
If a journal makes an article goes through the process of ‘peer-review’ before being published then it is a peer-review journal.
Yes Molecular Cancer is Peer-Reviewed Journal and Published by BioMed Central.
The Impact Factor is also known by the name of Journal Impact Factor of an Academic Journal.
It is based on the scientometric index that shows the annual average number of citations. Moreover, impact factor is having all the information which is published in the last two years in the given journal received.
The Impact Factor of Molecular Cancer is 10.679 (2024) Impact factor .
Molecular Cancer Impact Factor : | 10.679 (2024) |
Note : This information is taken from the Journal Citation Reports™ (Clarivate). | |
Visit for all Journals Impact factor List
Journal of Cancer and Tumor International (ISSN: 2454-7360) aims to publish high quality papers (Click here for Types of paper) in all areas of ‘Cancer and Tumor research’. This journal facilitates the research and wis...
Indian Journal of Cancer (ISSN 0019-509X), the show window of the progress of oncological sciences in India, was established in 1963. Indian Journal of Cancer is the first and only periodical serving the needs of all the specialti...
Ca-A Cancer Journal for Clinicians Published since 1950 by the American Cancer Society, CA: A Cancer Journal for Clinicians is one of the oldest peer-reviewed journals in oncology. The journal a...